Clinical TrialsSearch results
Number of results: 734
Other
- A PHASE 1/2 STUDY OF ORAL LOXO-292 IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING RET-FUSION NON-SMALL CELL LUNG CANCER, MEDULLARY THYROID CANCER, AND OTHER TUMORS WITH INCREASED RET ACTIVITY
- Advanced Solid Tumors, Including RET-Fusion Non Small Cell Lung Cancer, Medullary Thyroid Cancer, an
- Hokonohara Toshihiro
- 2022-07-02
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Patients With Duchenne Muscular Dystrophy (EMBARK)
- Duchenne Muscular Dystrophy
- O Malley Patrick
- 2021-12-25
Other
- A Phase 3 Study to Compare the Immunogenicity against COVID-19, of S-268019 to the ChAdOx1 nCoV-19 vaccine (COVID-19)
- Prevention of COVID-19
- Nagata Tsutae
- 2022-01-13
Other
- A Phase 3 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy
- Duchenne Muscular Dystrophy
- Kawai Norisuke
- 2021-04-22
Other
- A phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung cancer
- Non-small-cell lung cancer
- West Japan Oncology Group
- 2008-07-08
Other
- A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancer
- small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)
- advanced/recurrent gastric cancer
- OGSG
- 2009-07-10